Two Sigma Advisers, LP

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
2,360
Total Value
44417954494
Accession Number
0000899140-25-000679
Form Type
13F-HR
CIK
0001478735
Manager Name
Two Sigma Advisers, LP
Data Enrichment
97% identified
2,287 identified73 unidentified

Holdings

2,360 positions
Manager:
SEC
Search and click to pin securities to the top
Page 63 of 118
WABASH NATIONAL Corp
WNC|929566107
Shares:
148400(+59.4%)
Value:
$1.6B(+2.8%)
ASE Technology Holding Co., Ltd.
ASX|00215W100
Shares:
187100(-21.9%)
Value:
$1.6B(-32.1%)
Esquire Financial Holdings, Inc.
ESQ|29667J101
Shares:
21700(-31.5%)
Value:
$1.6B(-35.1%)
N-able, Inc.
NABL|62878D100
Shares:
230400(+207.6%)
Value:
$1.6B(+133.5%)
MEDICAL PROPERTIES TRUST INC
MPW|58463J304
Shares:
268100
Value:
$1.6B
National Storage Affiliates Trust
NSA|637870106
Shares:
41000(+13.6%)
Value:
$1.6B(+18.0%)
FIRST COMMONWEALTH FINANCIAL CORP /PA/
FCF|319829107
Shares:
103700(+630.3%)
Value:
$1.6B(+570.7%)
CBL & ASSOCIATES PROPERTIES INC
CBL|124830878
Shares:
60600(+114.1%)
Value:
$1.6B(+93.5%)
IDT CORP
IDT|448947507
Shares:
31200(+43.8%)
Value:
$1.6B(+55.2%)
MASCO CORP /DE/
MAS|574599106
Shares:
23000(-55.6%)
Value:
$1.6B(-57.5%)
Atea Pharmaceuticals, Inc.
AVIR|04683R106
Shares:
533000(+8.0%)
Value:
$1.6B(-3.6%)
Hayward Holdings, Inc.
HAYW|421298100
Shares:
114300(-44.1%)
Value:
$1.6B(-49.1%)
Amneal Pharmaceuticals, Inc.
AMRX|03168L105
Shares:
189049(+331.1%)
Value:
$1.6B(+356.2%)
4D Molecular Therapeutics, Inc.
FDMT|35104E100
Shares:
490400(+288.0%)
Value:
$1.6B(+125.0%)
Scorpio Tankers Inc.
STNG|Y7542C130
Shares:
41671(-39.2%)
Value:
$1.6B(-54.0%)
SKYWEST INC
SKYW|830879102
Shares:
17900(-9.1%)
Value:
$1.6B(-20.7%)
FIRST FINANCIAL CORP /IN/
THFF|320218100
Shares:
31899(-7.3%)
Value:
$1.6B(-1.7%)
64157F103
64157F103
Shares:
267500(+5.4%)
Value:
$1.6B(+65.5%)
G0457F107
G0457F107
Shares:
193634(+28.3%)
Value:
$1.6B(+42.1%)
Rithm Capital Corp.
RITM|64828T201
Shares:
136200
Value:
$1.6B